0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Viewpoint | 
Walid F. Gellad, MD, MPH; Kathryn E. Flynn, PhD; G. Caleb Alexander, MD, MS
JAMA. 2015;314(9):869-870. doi:10.1001/jama.2015.8405.

The JAMA Forum |  FREE
Gail Wilensky, PhD
JAMA. 2015;314(5):440-441. doi:10.1001/jama.2015.8733.

Research Letter | 
Sonja M. Swenson, BA; Lisa J. Chamberlain, MD, MPH; Lee M. Sanders, MD, MPH; et al.
JAMA. 2015;314(4):405-407. doi:10.1001/jama.2015.7169.

Editorial | 
Joshua M. Sharfstein, MD; Aaron S. Kesselheim, MD, JD, MPH
JAMA. 2015;314(3):233-234. doi:10.1001/jama.2015.7151.

Editorial | 
Phil B. Fontanarosa, MD, MBA; Howard Bauchner, MD; Robert M. Golub, MD
JAMA. 2015;314(3):235-236. doi:10.1001/jama.2015.8232.

Original Investigation | 
James D. Lewis, MD, MSCE; Laurel A. Habel, PhD; Charles P. Quesenberry, PhD; et al.
JAMA. 2015;314(3):265-277. doi:10.1001/jama.2015.7996.
Includes: CME, Supplemental Content

Viewpoint | 
Amitabh Chandra, PhD; Jacqueline Vanderpuye-Orgle, PhD
JAMA. 2015;314(3):225-226. doi:10.1001/jama.2015.6170.
Includes: Supplemental Content

News From the Food and Drug Administration | 
Rebecca Voelker, MSJ
JAMA. 2015;314(1):17. doi:10.1001/jama.2015.6855.

News From the Food and Drug Administration | 
Rebecca Voelker, MSJ
JAMA. 2015;314(1):17. doi:10.1001/jama.2015.7109.

Medical News & Perspectives | 
Tracy Hampton, PhD
JAMA. 2015;313(24):2411-2413. doi:10.1001/jama.2015.4738.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Psychiatry
Original Investigation  | 
Evaluation of Antipsychotic Dose Reduction in Late-Life Schizophrenia A Prospective Dopamine D2/3 Receptor Occupancy Study
Ariel Graff-Guerrero, MD, PhD; Tarek K. Rajji, MD; Benoit H. Mulsant, MD, MS; et al.
JAMA Oncology
From The JAMA Network  | 
Prognostic Significance of Cutaneous Adverse Events Associated With Pembrolizumab Therapy
Jennifer A. Lo, BA; David E. Fisher, MD, PhD; Keith T. Flaherty, MD
JAMA Pediatrics
Viewpoint  | 
Global Collaboration to Develop New and Existing Drugs for Neonates
Jonathan M. Davis, MD; Mark A. Turner, MB, PhD, MRCPCH
JAMA Dermatology
JAMA Dermatology Clinicopathological Challenge  | 
Erythematous Papules on the Forearms
Shilpi Khetarpal, MD; Ivanka Kovalyshyn, DO; Anthony P. Fernandez, MD, PhD